Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 04, 2015 10:55 PM ET

Healthcare Equipment and Supplies

Company Overview of Cellnovo Limited

Company Overview

Cellnovo Limited, a medical technology company, develops and markets diabetes management systems. The company markets insulin patch pump systems via a direct sales force in the United Kingdom and France. It also offers a handset that automatically and wirelessly records insulin dose, blood glucose, and physical activity. The company primarily addresses patients with type 1 diabetes who require insulin on a daily basis. Cellnovo Limited is based in Swansea, the United Kingdom.

25 Buckingham Gate

London,  SW1E 6LD

United Kingdom

Founded in 2002


44 20 3058 1250

Key Executives for Cellnovo Limited

Chief Executive Officer and Director
Executive Chairman
Age: 64
Chief Financial Officer and Director
Age: 51
Chief Technology Officer
Vice President of Administration
Compensation as of Fiscal Year 2015.

Cellnovo Limited Key Developments

Cellnovo Limited Hires Senior Management Team; Opens New Subsidiary in France with an Office in Paris

Cellnovo Limited announced the appointments of three executives to the senior management team. Bart Bergstein has been appointed as Chief Financial Officer, Steve Bubrick as Vice President Global Marketing and Business Development, and Didier Moire as Area Director of newly created Cellnovo France. Bart Bergstein has a 24 year track record in the financial industry including 14 years in Venture Capital. After joining the private equity arm of ABN AMRO in 1997, Bart established the AMRO Life Sciences Team that later spun out as Forbion Capital Partners. Steve Bubrick has more than 20 years of experience in the diabetes industry. He joins Cellnovo from Asante Solutions where he held the position of Vice President Commercial Operations. Prior to Asante, Steve held senior commercial positions at Insulet, Abbott, Therasense and Lifescan where he was involved in bringing disruptive monitoring and insulin delivery products to markets worldwide. Steve will also be in charge of laying the foundations of Cellnovo's business in North America, starting with overseeing its regulatory filing process. Recognizing the importance of the diabetes market in France, Cellnovo has created a subsidiary in the country with an office in Paris, where Didier Moire will be based and responsible for sales in France, Belgium and Luxembourg. Didier has more than 25 years' experience in Medical Technology and Diagnostics. He was previously Managing Director France/Benelux for Immucor and also held senior positions in Chiron and Novartis.

Similar Private Companies By Industry

Company Name Region
Nimrodental Ltd. Europe
Metrasens Ltd. Europe
Star Syringe Ltd. Europe
POWERbreathe International Limited Europe
Mode Dx Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cellnovo Limited, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at